Csenge Advisory Group’s Trueblue TBI Stock Holding History

Csenge Advisory Group’s Portfolio TBI Stock Details TBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-14	Closed	–	–	1333
2018 Q3	$0	Buy	+14	New	+$389	﹤0.01%	1578

Other funds holding TBI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Csenge Advisory Group's TBI Position: Q4 2018 in Review

Csenge Advisory Group sold out of Trueblue (TBI) in Q4 2018, closing a stake of 14 shares.

Csenge Advisory Group first reported a position in TBI in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 186 funds tracked by Wall St. Rank hold TBI as of Q4 2018.

Csenge Advisory Group reported no remaining Trueblue position as of Q4 2018 after selling out during the quarter.
Csenge Advisory Group sold 14 Trueblue shares in Q4 2018.
Csenge Advisory Group first reported a position in Trueblue in Q3 2018 and held it in 1 quarter.
Csenge Advisory Group's Trueblue position peaked at $0 in Q3 2018.
186 funds tracked by Wall St. Rank held Trueblue as of Q4 2018.

Based on Csenge Advisory Group's 13F filing for Q4 2018, filed 7 Feb 2019.